[Sponsored Report] Dong-A makes ancient treatment affordable

Home > National > Guest Reports

print dictionary print

[Sponsored Report] Dong-A makes ancient treatment affordable


Dong-A Pharmaceutical’s “D.C Daily” helps strengthen respiratory immunity. [DONG-A PHARMACEUTICAL]

Dong-A Pharmaceutical has developed a new product, “D.C Daily,” made from cordyceps, an ingredient known in Oriental medicine for its ability to boost immunity from respiratory illnesses such as asthma and chest colds.

Cordyceps is a fungus that traditionally grows on insects. Along with ginseng and deer antlers, it is one of the three medicines said to bring eternal youth in East Asian folklore. The fungus has long been studied in Korea for its effectiveness in boosting immunity, preventing aging, improving fatigue and fighting cancer.

However, cordyceps has typically been too expensive for ordinary people to consume due to the sensitive conditions required for its cultivation.

The situation was recently improved by Prof. Sung Jae-Mo of Kangwon National University, a renowned cordyceps specialist.

After much research, Prof. Sung developed a new cultivation method to grow cordyceps on brown rice rather than insects, which substantially lowered the costs incurred from the cultivation process.

To prove the immunity-strengthening effect of cordyceps cultivated on brown rice, Dong-A Pharmaceutical gave healthy adult males the substance for four weeks. According to the results, their immune cells increased by 27 percent, and the activity of those cells increased by 11 percent.

Last March, Dong-A Pharmaceutical received official certification from the Korea Food and Drug Administration that D.C Daily is effective in strengthening immunity.

The product is recommended to be taken as two pills, twice a day.

BY SONG KYOUNG-SON [song.kyoungson@joongang.co.kr]
Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)